FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 65 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,000 | 0.0% | 1,100 | +10.0% | 0.00% | – |
Q3 2019 | $3,000 | -25.0% | 1,000 | -33.3% | 0.00% | – |
Q2 2019 | $4,000 | -33.3% | 1,500 | 0.0% | 0.00% | – |
Q1 2019 | $6,000 | +20.0% | 1,500 | 0.0% | 0.00% | – |
Q4 2018 | $5,000 | -44.4% | 1,500 | 0.0% | 0.00% | – |
Q3 2018 | $9,000 | +80.0% | 1,500 | +50.0% | 0.00% | – |
Q2 2018 | $5,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
Q4 2017 | $6,000 | -95.1% | 1,000 | -95.5% | 0.00% | -100.0% |
Q3 2017 | $122,000 | +14.0% | 22,000 | -4.3% | 0.00% | 0.0% |
Q2 2017 | $107,000 | +2040.0% | 23,000 | +2200.0% | 0.00% | – |
Q1 2017 | $5,000 | -54.5% | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $11,000 | +22.2% | 1,000 | 0.0% | 0.00% | – |
Q3 2016 | $9,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $6,000 | -14.3% | 1,000 | 0.0% | 0.00% | – |
Q1 2016 | $7,000 | -12.5% | 1,000 | 0.0% | 0.00% | – |
Q4 2015 | $8,000 | -27.3% | 1,000 | -33.3% | 0.00% | – |
Q3 2015 | $11,000 | +37.5% | 1,500 | +100.0% | 0.00% | – |
Q2 2015 | $8,000 | +60.0% | 750 | +50.0% | 0.00% | – |
Q1 2015 | $5,000 | +25.0% | 500 | 0.0% | 0.00% | – |
Q4 2014 | $4,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,293,177 | $4,643,000 | 4.08% |
GREAT POINT PARTNERS LLC | 4,047,561 | $14,531,000 | 1.84% |
Sio Capital Management, LLC | 1,151,510 | $4,134,000 | 1.51% |
DAFNA Capital Management LLC | 808,000 | $2,901,000 | 1.44% |
Diag Capital Management, LP | 146,432 | $960,000 | 1.10% |
Perceptive Advisors | 4,661,824 | $15,850,000 | 0.60% |
Eversept Partners, LP | 294,660 | $1,057,829 | 0.57% |
Sofinnova Investments, Inc. | 832,293 | $2,987,000 | 0.37% |
KNOTT DAVID M | 206,200 | $740,000 | 0.35% |
Orbimed Advisors | 5,195,330 | $18,651,000 | 0.34% |